- $1.59m
- -$3.49m
- $9.44m
Curis Inc expected to post a loss of $2.12 a share - Earnings Preview
Curis Inc expected to post a loss of $2.12 a share - Earnings Preview
Brief: Curis Inc Files For Stock Shelf Of Up To $300 Million – SEC Filing
Curis Inc reports results for the quarter ended in December - Earnings Summary
Brief: Curis Provides Fourth Quarter 2023 Business Update
Curis Inc expected to post a loss of $2.11 a share - Earnings Preview
Brief: Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma
U.S. STOCKS ON THE MOVE-Copart, Expedia, Chevron
U.S. RESEARCH ROUNDUP- Airbnb, Brookdale Senior Living, Chevron
Curis Inc reports results for the quarter ended in September - Earnings Summary
Curis Inc expected to post a loss of $2.33 a share - Earnings Preview
Brief: Curis Announces Date For The 2nd Symposium On IRAK4 In Cancer
Curis Inc reports results for the quarter ended in June - Earnings Summary
Curis Inc expected to post a loss of 12 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Microsoft, Genius Sports, Thermo Fisher
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Applied Digital, Sweetgreen
Curis down on $15 mln at-the-market offering
Brief: Curis Announces $15.1 Mln Registered Direct Offering
Brief: FDA Removes Partial Clinical Hold On TakeAim Leukemia Study RP2D Established At 300 Mg BID